Navigation Links
An Important Message to Anyone Taking Viagra ... From The Women Who Love You ... and Zoller Labs
Date:3/12/2008

New 'It takes more than Viagra(R)' commercial on YouTube strikes a chord

with frustrated women

SALT LAKE CITY, March 12 /PRNewswire/ -- The new Zantrex(R)-3 Insta*Shot(TM) commercial is really funny ... but with serious undertones.

"I love the commercial because sometimes my husband remembers to take his Viagra but forgets to stay awake long enough for it to make any difference," says a customer service rep (who wishes to remain anonymous) at Zoller(R) Labs, the makers of Zantrex-3. "When we first showed the commercial to our employees the men looked embarrassed. Meanwhile the women were nodding their heads in complete agreement. Maybe it's just my female perspective but really, what good is a male potency pill if your significant other doesn't even have the energy to stay awake?"

The commercial for Zantrex-3 Insta*Shot(TM), which can now be seen on YouTube (search Zantrex3) depicts an all too common scene ... men too exhausted by their hectic schedules to be interested in anything but sleep. And, of course, there's the female frustration. The commercial's opening line says it all: "No matter how much Viagra you take ... you still need energy to make things 'happen.'"

There's no question that over the past five years the Zantrex-3 brand has become synonymous with extreme energy (even though Zantrex-3 diet pills are found in the weight loss section of virtually every store in America that has a weight loss section). So it was only a matter of time before the clever marketers at Zantrex entered the new, ultra-hip energy shot market. But rather than concentrate on extreme sports (although they have a very cool "free-running" commercial and sponsor MMA legend "Dangerous" Dan Henderson), Zantrex-3 Insta*Shot is focusing on the overly-exhausted, over-40 male market with one of the funniest, if not most interesting, commercials of the year, especially for an energy shot.

"Our tongue-in-cheek approach hide
'/>"/>

SOURCE Zoller Labs
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives
2. Love and Diabetes: dLife Valentines Day Quiz Tests and Teaches Important Relationship Lessons for People With Diabetes
3. Sleep duration may play important role in childhood obesity
4. Telephone Nursing an Important Component of Managed Healthcare
5. Independence Blue Cross Delivers Important Reminder to Women during Cervical Cancer Awareness Month
6. New Cleaning Industry Topics Page Provides Important Safety and Health Resources
7. The most important candidate genes for pancreatic stone formation
8. Research highlights important indicators of early-stage ovarian cancer
9. Quality of life: most important predictor of survival for advanced NSCLC patients
10. Video: Holiday Safety Is Important
11. Schwarzenegger Signs Bill to Remove Written Informed Consent for HIV Testing; "Most Important Change in Public HIV/AIDS Policy in Years," Says AHF

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...NFRANCISCO,Nov.25/PRNewswire/--IntroducingPariBeau...smeticsandadvancedskincarededicatedtoprovidingpres...isthefirstprestigeskincareandcolorcosmeticbrandtol...tores,withofficesinSanFranciscoandToronto,wasfound...essionalswithover35yearsexperienceintheindustry.Pa...
(Date:11/25/2009)... Dentistry is evolving beyond the t...overs. In fact, it is looking at these more tradit...eservation and beauty of teeth is what the public ...now, more than ever, an important part of the medi...oral and systemic health is being strengthened eve...
(Date:11/25/2009)... Dr. Neil J. Zemmel, a board-certif...new website utilizing the latest internet technolo...reast reconstruction procedures. The new site inco... interactive web experience that’s designed ...r of Dr. Zemmel’s practice. , ...
(Date:11/25/2009)... Partners Consulting again commits ...ance. , (PRWEB) November ...ounced that their Data Center operation has comple...ountants’ Statement on Auditing Standards (S...ally recognized audit for validating the internal ...
(Date:11/25/2009)... The American Society of Hematology... publishing, education, and media company, are lau... a dynamic science curriculum designed to spark in...ddition to exposing students to exciting career op... Washington (PRWEB) November 25, 2009 -- The Am...
Breaking Medicine News(10 mins):Health News:Pari Beauty Professional Artistry 2Health News:Local Dentist Teaches Other Dentists How to Save the Lives of Their Patients 2Health News:Local Dentist Teaches Other Dentists How to Save the Lives of Their Patients 3Health News:Richmond, Virginia Plastic Surgeon Launches State-of-the-Art Breast Surgery Website 2Health News:Richmond, Virginia Plastic Surgeon Launches State-of-the-Art Breast Surgery Website 3Health News:Richmond, Virginia Plastic Surgeon Launches State-of-the-Art Breast Surgery Website 4Health News:Partners Consulting Completes SAS70 Audit 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 3
... Aug. 4 U.S. Preventive Medicine, the leader in,d...pleted its participation,in a major pilot project ...(NCQA) to evaluate The Prevention Plan(TM), its gr... the agreement, U.S. Preventive Medicine is one of...
...ORO, N.C., Aug. 4 Medical Justice Services,Inc., ...sts defend,themselves against meritless medical ma...roduced a new way for physicians and dentists to f...nd blogs, solves a problem that,s exploded in the,...
...SBURGH, Aug. 4 Antiretroviral drugs for HIV do no...a central risk factor for heart disease, according...aduate School of Public Health to be published in ... protection against atherosclerosis hardening of ...
... In the white paper, "All ...tes Senior Consultant Jay Gordon Cone provides a m...s leaders assess if their teams are high-performin...environments. Yet in many companies, http://www.i...
... A paper published in the Inter...the Fudan-Cinpathogen Clinical and Molecular Resea...aboration with the University of Colorado, and Cin...iagnosis and classification were performed by a si...
...vals consistent with current US treatment guidelin...mbination therapies, - Up to 80% of patients may ... blood pressure goals, - Singl...e approvals may benefit patients who are likely to...
Other Medicine News:Health News:National Committee for Quality Assurance Selects U.S. Preventive Medicine for Health Promotion Pilot Project 2Health News:Medical Justice Services Inc. Now Offers Online Anti-Defamation Service 2Health News:Medical Justice Services Inc. Now Offers Online Anti-Defamation Service 3Health News:Long-term HIV treatment may reduce risk for atherosclerosis 2Health News:New White Paper by Performance Improvement Innovator Interaction Associates Helps Business Leaders Assess Team Effectiveness 2Health News:Fudan-Cinpathogen Study Shows Chronic Lymphoid Neoplasms are More Common in Shanghai Than Thought 2Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 2Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 3Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 4Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 5Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 6Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 7
(Date:11/24/2009)...Newswire/--Inadditiontofamily,friendsandhealth,can...toherThanksgivinggratitudelist. ,, "Theyheardth...esaidofMonday,sverdictstotaling$103millionindamage...g12,000womennationwidewhohavesuedWyethandPfizerpha...nandPrempro.Wisneskiandtheothervictimsofhormonethe...
(Date:11/24/2009)...RNewswire/--SpartaSystems,Inc.,themakerofTrackWise...mpliancesolutions,todayannouncedthatSSLInternation...eparentcompanyforgloballyrecognizedbrandssuchasDur...ityManagementSystem(EQMS).Thecompanyisnowleveragin...operationsthatincludeCorrectiveandPreventiveAction...
(Date:11/24/2009)...Newswire-Asia/--HuifengBio-Pharmaceutical,Technolo...dproducer,ofplantextractsandpharmaceuticalrawmater...oductioninXi,an,China,todayreportedthatinits,third..., RevenuesforthequarterendedSept.30,2009were$...23forthesamequarterin2008.Netincome,amountedto1,00...
Breaking Medicine Technology:Maryland Woman Thankful for Wyeth Verdicts 2SSL International plc Embraces TrackWise(R) Software for Global Quality and Compliance Efforts 2SSL International plc Embraces TrackWise(R) Software for Global Quality and Compliance Efforts 3Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 2Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 3Improving schools for disabled students is NJIT researchers mission 59864 1Improving schools for disabled students is NJIT researchers mission 59864 2Improving schools for disabled students is NJIT researchers mission 59864 3Penn team uses self assembly to make molecule sized particles with patches of charge 10447 1Penn team uses self assembly to make molecule sized particles with patches of charge 10447 2Experts Issue Call to Reconsider Screening for Breast Cancer and Prostate Cancer 59862 1Experts Issue Call to Reconsider Screening for Breast Cancer and Prostate Cancer 59862 2Experts Issue Call to Reconsider Screening for Breast Cancer and Prostate Cancer 59862 3Experts Issue Call to Reconsider Screening for Breast Cancer and Prostate Cancer 59862 4Experts Issue Call to Reconsider Screening for Breast Cancer and Prostate Cancer 59862 5Experts Issue Call to Reconsider Screening for Breast Cancer and Prostate Cancer 59862 6
...SCO, Dec. 8 Millennium: The Takeda Oncology Compa...d follow up of patients from the large, internatio...vival improvement for patients with previously unt...nd prednisone (VcMP). The VELCADE combination demo...oups, including those with poor prognostic charact...
...SCO, Dec. 8 Millennium: The Takeda Oncology,Compa...multi-center,randomized Phase III clinical trials ...eatment of transplant-eligible patients with previ...rogression-free survival (PFS) was observed,in one...ith vincristine,adriamycin and dexamethasone (VAD)...
Other Medicine Technology:Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 2Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 3Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 4Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 5Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 6Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 2Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 3Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 4Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 5Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 6Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 7
Kuglen Push-Pull Hook
Serdarevic Suture Hook
Sinskey Hook II
Lewicky Hook
Medicine Products: